Goetze TO, Stein A, Lorenzen S, Habibzada T, et al. Ramucirumab beyond progression plus TAS-102 in patients with advanced or metastatic esophagogastric adenocarcinoma, after treatment failure on a ramucirumab-based therapy. Int J Cancer 2023;153:1726-1733.
PMID: 37455496